General Bioactive Libraries cover nearly 20,000 known biologically active small molecules, including Bioactive Compound Library, Approved Drug Library, Clinical Compound Library, FDA-Approved Drug Library, and Featured Novel Bioactive Compound Library. They are suitable for drug repurposing, target identification, pharmacological studies and cell induced differentiation, and can be used for high-throughput and high-intensity screening.
| カタログ番号 | 製品名 | ||
|---|---|---|---|
| L4010 | Bioactive Compounds Library Max | A collection of 20980 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification. | 20980 compounds |
| L4200 | FDA-Approved Drug Library | A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); | 1729 compounds |
| L9200 | Drug Repurposing Compound Library | A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | 4240 compounds |
| L3400 | Clinical Compound Library | A unique collection of 3142 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); | 3142 compounds |
| L4150 | Featured Novel Bioactive Compound Library | It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of 990 compounds without compro | 990 compounds |
| L4000 | Bioactive Compound Library | TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 12862 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other research. | 12862 compounds |
| L1000 | Approved Drug Library | A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); | 2863 compounds |
